Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

CDC Responds: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax December 21, 2001

Title Adobe Acrobat Reader PDF Microsoft Word Word Microsoft PowerPoint PowerPoint
CDC Responds: Update on Options for Preventive Treatment for Persons at Risk for Inhalational Anthrax December 21, 2001 Transcript in PDF (198 KB/21 pages)    
Opening statements: Jim Hughes PDF (548 KB/2 pages)  Word (23 KB/2 pages)  
Speaker 1: Brad Perkins --- Rationale for 3 treatment options (including antibiotic efficacy and vaccine efficacy) PDF (556 KB/16 pages)   PowerPoint (1.79 MB/16 slides)
Speaker 2: Jai Lingappa --- Explanation and protocol for Anthrax vaccine option (including IND, and consent issues) PDF (268 KB/12 pages)   PowerPoint (1.79 MB/12 slides)
Speaker 3: Nancy Rosenstein --- Adherence and adverse events associated with post-exposure chemoprophylaxis PDF (345 KB/14 pages)   PowerPoint (214 KB/14 slides)
Speaker 4: Julie Gerberding --- Summary of treatment options (what we do/do not know) PDF (399 KB/16 pages)   PowerPoint (189 KB/16 slides)
  • Page last updated November 19, 2012
Contact Us:
Ready.gov - Prepare. Plan. Stay Informed.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #